Abstract
Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have